Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

2019105 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet HIV

Volume 6, Issue 10, pp. e667-e679

Field-Weighted Citation Impact: 6.50